Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Sponsor urges ban on state purchases of naloxone from companies tied to opioid settlements; DOJ flags supply risks
Summary
Sen. Mike Yakawich’s SB 112 would prohibit state purchases of opioid antagonists from manufacturers involved in opioid litigation; tribal leaders, medical groups supported it as a moral stance while the Department of Justice warned about potential supplier consolidation and procurement tradeoffs.
Senator Mike Yakawich told the House Health and Human Services Committee he brought Senate Bill 112 as a "bill of conscience," asking the state to avoid purchasing opioid antagonists from companies that played a role in fueling the opioid epidemic.
"Don't pay the arsonist for starting the fire," Yakawich said, summarizing the bill's intent to prevent the state from buying naloxone or equivalent products from companies involved in opioid settlements.
Tribal representatives and medical groups urged support. Patrick Yawaki, representing Fort Belknap and other tribal communities,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
